British Business Bank leads Microbiotica’s GBP 36 million Series C
The Cambridge microbiome drug developer announced the first close of a GBP 36 million (USD 48 million) Series C; IP Group put in GBP 4 million and puts its 16.4% stake after second completion at GBP 24.1 million.